1
NAPSRx CNPR Exam 2026/2027 Actual
Exam | 160 Questions with 100% Correct
Answers | Revised 18th Edition Verified |
Pass Guaranteed - A+ Graded
Section 1: Pharmaceutical Industry Overview (20 Questions)
Q1: The federal agency responsible for approving new drugs in the United States is:
A. DEA (Drug Enforcement Administration)
B. FDA (Food and Drug Administration) [CORRECT]
C. FTC (Federal Trade Commission)
D. CMS (Centers for Medicare and Medicaid Services)
Correct Answer: B
Rationale: The FDA is responsible for protecting public health by ensuring the safety, efficacy,
and security of human drugs, biological products, and medical devices. The DEA enforces
controlled substance laws.
Q2: The Hatch-Waxman Act of 1984 is significant because it:
A. Established Medicare Part D
B. Created the generic drug approval pathway (ANDA) [CORRECT]
C. Prohibited off-label promotion
D. Established the FDA
Correct Answer: B
Rationale: The Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman Act)
created the Abbreviated New Drug Application (ANDA) process, allowing generic
manufacturers to rely on the safety and efficacy data of brand-name drugs, significantly speeding
up generic drug entry.
,2
Q3: The Prescription Drug User Fee Act (PDUFA) allows the FDA to:
A. Collect fees from drug manufacturers to fund and expedite drug review processes
[CORRECT]
B. Ban all prescription drugs
C. Set drug prices
D. Regulate generic drugs only
Correct Answer: A
Rationale: PDUFA authorizes the FDA to collect user fees from pharmaceutical companies
submitting New Drug Applications (NDAs). These funds are used to hire additional reviewers
and upgrade systems, reducing the time required for drug approval.
Q4: A "blockbuster drug" is defined as a drug with annual sales exceeding:
A. $500 million
B. $1 billion [CORRECT]
C. $5 billion
D. $10 billion
Correct Answer: B
Rationale: In the pharmaceutical industry, a blockbuster drug is one that generates annual
revenues exceeding $1 billion for the pharmaceutical company.
Q5: The generic drug approval process is established under:
A. Hatch-Waxman Act [CORRECT]
B. Food, Drug, and Cosmetic Act
C. Orphan Drug Act
D. PDUFA
,3
Correct Answer: A
Rationale: The Hatch-Waxman Act established the legal framework for generic drug approval via
the ANDA process, balancing the interests of brand-name and generic manufacturers.
Q6: An orphan drug is designed to treat:
A. Common conditions affecting millions
B. Rare diseases affecting fewer than 200,000 people in the U.S. [CORRECT]
C. Pediatric conditions exclusively
D. Chronic conditions in the elderly
Correct Answer: B
Rationale: The Orphan Drug Act defines an orphan drug as one intended to treat a rare disease or
condition affecting fewer than 200,000 persons in the U.S., or one for which there is no
reasonable expectation that the cost of developing the drug will be recovered from sales.
Q7: The FDA's Fast Track designation is intended to:
A. Slow down drug approval for safety checks
B. Expedite development and review of drugs for serious conditions with unmet medical need
[CORRECT]
C. Approve generic drugs more quickly
D. Regulate over-the-counter drug switches
Correct Answer: B
Rationale: Fast Track designation facilitates the development and expedites the review of drugs
to treat serious conditions and fill an unmet medical need, allowing for more frequent FDA
interactions and rolling reviews.
Q8: The "Orange Book" is published by the FDA and contains:
, 4
A. Approved drug products with therapeutic equivalence evaluations [CORRECT]
B. Clinical trial results for pending drugs
C. Drug wholesale pricing lists
D. Pharmacy licensing regulations
Correct Answer: A
Rationale: Officially titled "Approved Drug Products with Therapeutic Equivalence
Evaluations," the Orange Book identifies drug products approved on the basis of safety and
effectiveness by the FDA and contains therapeutic equivalence evaluations.
Q9: The primary mission of the FDA is to:
A. Maximize drug company profits
B. Protect public health by ensuring safety, efficacy, and security of drugs [CORRECT]
C. Regulate drug prices to ensure affordability
D. Promote international drug sales
Correct Answer: B
Rationale: The FDA is responsible for protecting the public health by assuring the safety,
efficacy, and security of human and veterinary drugs, biological products, medical devices, the
food supply, and tobacco products.
Q10: The DEA (Drug Enforcement Administration) regulates:
A. All prescription drugs and medical devices
B. Controlled substances under the Controlled Substances Act [CORRECT]
C. Over-the-counter medications
D. Biological products and vaccines
Correct Answer: B
NAPSRx CNPR Exam 2026/2027 Actual
Exam | 160 Questions with 100% Correct
Answers | Revised 18th Edition Verified |
Pass Guaranteed - A+ Graded
Section 1: Pharmaceutical Industry Overview (20 Questions)
Q1: The federal agency responsible for approving new drugs in the United States is:
A. DEA (Drug Enforcement Administration)
B. FDA (Food and Drug Administration) [CORRECT]
C. FTC (Federal Trade Commission)
D. CMS (Centers for Medicare and Medicaid Services)
Correct Answer: B
Rationale: The FDA is responsible for protecting public health by ensuring the safety, efficacy,
and security of human drugs, biological products, and medical devices. The DEA enforces
controlled substance laws.
Q2: The Hatch-Waxman Act of 1984 is significant because it:
A. Established Medicare Part D
B. Created the generic drug approval pathway (ANDA) [CORRECT]
C. Prohibited off-label promotion
D. Established the FDA
Correct Answer: B
Rationale: The Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman Act)
created the Abbreviated New Drug Application (ANDA) process, allowing generic
manufacturers to rely on the safety and efficacy data of brand-name drugs, significantly speeding
up generic drug entry.
,2
Q3: The Prescription Drug User Fee Act (PDUFA) allows the FDA to:
A. Collect fees from drug manufacturers to fund and expedite drug review processes
[CORRECT]
B. Ban all prescription drugs
C. Set drug prices
D. Regulate generic drugs only
Correct Answer: A
Rationale: PDUFA authorizes the FDA to collect user fees from pharmaceutical companies
submitting New Drug Applications (NDAs). These funds are used to hire additional reviewers
and upgrade systems, reducing the time required for drug approval.
Q4: A "blockbuster drug" is defined as a drug with annual sales exceeding:
A. $500 million
B. $1 billion [CORRECT]
C. $5 billion
D. $10 billion
Correct Answer: B
Rationale: In the pharmaceutical industry, a blockbuster drug is one that generates annual
revenues exceeding $1 billion for the pharmaceutical company.
Q5: The generic drug approval process is established under:
A. Hatch-Waxman Act [CORRECT]
B. Food, Drug, and Cosmetic Act
C. Orphan Drug Act
D. PDUFA
,3
Correct Answer: A
Rationale: The Hatch-Waxman Act established the legal framework for generic drug approval via
the ANDA process, balancing the interests of brand-name and generic manufacturers.
Q6: An orphan drug is designed to treat:
A. Common conditions affecting millions
B. Rare diseases affecting fewer than 200,000 people in the U.S. [CORRECT]
C. Pediatric conditions exclusively
D. Chronic conditions in the elderly
Correct Answer: B
Rationale: The Orphan Drug Act defines an orphan drug as one intended to treat a rare disease or
condition affecting fewer than 200,000 persons in the U.S., or one for which there is no
reasonable expectation that the cost of developing the drug will be recovered from sales.
Q7: The FDA's Fast Track designation is intended to:
A. Slow down drug approval for safety checks
B. Expedite development and review of drugs for serious conditions with unmet medical need
[CORRECT]
C. Approve generic drugs more quickly
D. Regulate over-the-counter drug switches
Correct Answer: B
Rationale: Fast Track designation facilitates the development and expedites the review of drugs
to treat serious conditions and fill an unmet medical need, allowing for more frequent FDA
interactions and rolling reviews.
Q8: The "Orange Book" is published by the FDA and contains:
, 4
A. Approved drug products with therapeutic equivalence evaluations [CORRECT]
B. Clinical trial results for pending drugs
C. Drug wholesale pricing lists
D. Pharmacy licensing regulations
Correct Answer: A
Rationale: Officially titled "Approved Drug Products with Therapeutic Equivalence
Evaluations," the Orange Book identifies drug products approved on the basis of safety and
effectiveness by the FDA and contains therapeutic equivalence evaluations.
Q9: The primary mission of the FDA is to:
A. Maximize drug company profits
B. Protect public health by ensuring safety, efficacy, and security of drugs [CORRECT]
C. Regulate drug prices to ensure affordability
D. Promote international drug sales
Correct Answer: B
Rationale: The FDA is responsible for protecting the public health by assuring the safety,
efficacy, and security of human and veterinary drugs, biological products, medical devices, the
food supply, and tobacco products.
Q10: The DEA (Drug Enforcement Administration) regulates:
A. All prescription drugs and medical devices
B. Controlled substances under the Controlled Substances Act [CORRECT]
C. Over-the-counter medications
D. Biological products and vaccines
Correct Answer: B
